4
Changes in Ownership
MAIA Biotechnology, Inc. Filed Acc 0001127602-25-018655
Options or other derivatives
- Director acquired 25,232 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Louie Ngar Yee Director | 2025-06-30 | Grant or award · Stock Options | +25,232 | 25,232 | D: show line 1 in the form |
Loading xslF345X05/form4.xml…